adenovirus vector E2b-deleted vaccine (E.C7 cell line) (Etubics/Michigan State University)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nameadenovirus vector E2b-deleted vaccine (E.C7 cell line) (Etubics/Michigan State University)
Drug Alias Nameadenovirus vector E2b-deleted malaria vaccine (Etubics/Michigan State University)
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Recombinant vector vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsMalaria
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEtubics Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsMalaria

Other Information

ATC CodeN/A
Related LinksN/A